Sfoglia per RIVISTA
CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH
Collezione AOU Novara

  

Items : 8

Early Hepatic Decompensation Identifies Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab or Sorafenib at Highest Risk of Death. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2025 Feb 3;31(3):543-550. doi: 10.1158/1078-0432.CCR-24-2582.

2025
AOU Novara

Cabibbo G; Celsa C; Battaglia S; Enea M; Di Maria G; Grova A; Ciccia R; Manfredi GF; Iavarone M; Vogel A; Singal AG; Reig M; Pinato DJ; Cammà C;

Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line Chemotherapy. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2025 Feb 17;31(4):707-718. doi: 10.1158/1078-0432.CCR-24-0924.

2025
AOU Novara

Ghidini M; Hahne JC; Senti C; Heide T; Proszek PZ; Shaikh R; Carter P; Hubank M; Trevisani F; Garrone O; Cappelletti MR; Generali D; Cattaneo M; Gnocchi N; Donati G; Gobbi A; Grizzi G; Lampis A; Elghadi R; Tanzi G; Tomasello G; Ratti M; Pinato DJ; Fassan M; Vlachogiannis G; Sottoriva A; Cortellini A; Passalacqua R; Valeri N; et alii...

Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2024 May 15;30(10):2140-2159. doi: 10.1158/1078-0432.CCR-23-2748.

2024
AOU Novara

Hedayat S; Cascione L; Cunningham D; Schirripa M; Lampis A; Hahne JC; Tunariu N; Hong SP; Marchetti S; Khan K; Fontana E; Angerilli V; Delrieux M; Nava Rodrigues D; Procaccio L; Rao S; Watkins D; Starling N; Chau I; Braconi C; Fotiadis N; Begum R; Guppy N; Howell L; Valenti M; Cribbes S; Kolozsvari B; Kirkin V; Lonardi S; et alii...

Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2023 Jul 14;29(14):2714-2724. doi: 10.1158/1078-0432.CCR-22-3116.

2023
AOU Novara

Cortellini A; D'Alessio A; Cleary S; Buti S; Bersanelli M; Bordi P; Tonini G; Vincenzi B; Tucci M; Russo A; Pantano F; Russano M; Stucci LS; Sergi MC; Falconi M; Zarzana MA; Santini D; Spagnolo F; Tanda ET; Rastelli F; Giorgi FC; Pergolesi F; Giusti R; Filetti M; Lo Bianco F; Marchetti P; Botticelli A; Gelibter A; Siringo M; et alii...

Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non-Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2019 Dec 15;25(24):7312-7319. doi: 10.1158/1078-0432.CCR-19-0994. Epub 2019 Aug 15.

2019
AOU Novara

Landi L; Chiari R; Tiseo M; D'Incà F; Dazzi C; Chella A; Delmonte A; Bonanno L; Giannarelli D; Cortinovis DL; de Marinis F; Borra G; Morabito A; Gridelli C; Galetta D; Barbieri F; Grossi F; Capelletto E; Minuti G; Mazzoni F; Verusio C; Bria E; Alì G; Bruno R; Proietti A; Fontanini G; Crinò L; Cappuzzo F;

Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2016 Aug 1;22(15):3961-70. doi: 10.1158/1078-0432.CCR-15-2547. Epub 2016 Feb 26.

2016
AOU Novara

Bossi P; Bergamini C; Siano M; Cossu Rocca M; Sponghini AP; Favales F; Giannoccaro M; Marchesi E; Cortelazzi B; Perrone F; Pilotti S; Locati LD; Licitra L; Canevari S; De Cecco L;

Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2013 Nov 1;19(21):5890-900. doi: 10.1158/1078-0432.CCR-13-0622. Epub 2013 Sep 13.

2013
AOU Novara

Massucco C; Recchia AG; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Mosca L; Morabito F; Colombo M; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; et alii...

The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2009 Feb 1;15(3):995-1004. doi: 10.1158/1078-0432.CCR-08-1630.

2009
AOU Novara

Rossi D; Cerri M; Deambrogi C; Sozzi E; Cresta S; Rasi S; De Paoli L; Spina V; Gattei V; Capello D; Forconi F; Lauria F; Gaidano G;